Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Local bacteria affect the efficacy of chemotherapeutic drugs.

Lehouritis P, Cummins J, Stanton M, Murphy CT, McCarthy FO, Reid G, Urbaniak C, Byrne WL, Tangney M.

Sci Rep. 2015 Sep 29;5:14554. doi: 10.1038/srep14554.

2.

Bacterial-mediated DNA delivery to tumour associated phagocytic cells.

Byrne WL, Murphy CT, Cronin M, Wirth T, Tangney M.

J Control Release. 2014 Dec 28;196:384-93. doi: 10.1016/j.jconrel.2014.10.030. Epub 2014 Nov 17.

PMID:
25466954
3.

Enhancement of electroporation facilitated immunogene therapy via T-reg depletion.

Forde PF, Sadadcharam M, Hall LJ, O' Donovan TR, de Kruijf M, Byrne WL, O' Sullivan GC, Soden DM.

Cancer Gene Ther. 2014 Aug;21(8):349-54. doi: 10.1038/cgt.2014.35. Epub 2014 Jul 18.

4.

Use of optical imaging to progress novel therapeutics to the clinic.

Byrne WL, DeLille A, Kuo C, de Jong JS, van Dam GM, Francis KP, Tangney M.

J Control Release. 2013 Dec 10;172(2):523-34. doi: 10.1016/j.jconrel.2013.05.004. Epub 2013 May 13. Review.

PMID:
23680286
5.

Targeting regulatory T cells in cancer.

Byrne WL, Mills KH, Lederer JA, O'Sullivan GC.

Cancer Res. 2011 Nov 15;71(22):6915-20. doi: 10.1158/0008-5472.CAN-11-1156. Epub 2011 Nov 8. Review.

6.

Peak B endorphin concentration in cerebrospinal fluid: reduced in chronic pain patients and increased during the placebo response.

Lipman JJ, Miller BE, Mays KS, Miller MN, North WC, Byrne WL.

Psychopharmacology (Berl). 1990;102(1):112-6.

PMID:
2144051
7.

Partial characterization of a novel endogenous opioid in human cerebrospinal fluid.

Miller BE, Lipman JJ, Byrne WL.

Life Sci. 1987 Dec 7;41(23):2535-45.

PMID:
3683089
8.

The effect of morphine upon CSF opioids in dogs.

Noel MA, Byrne WL.

Neuropeptides. 1985 Feb;5(4-6):429-32.

PMID:
4000416
9.
10.

Decreased normorphine sensitivity of maternal guinea pig ilea at parturition.

Kelly TG, Aloyo VJ, Ungar AL, Codd EE, Byrne WL.

Eur J Pharmacol. 1981 Dec 3;76(2-3):278-80.

PMID:
7333361
11.

Effects of beta-endorphin and morphine on the sleep-wakefulness behavior of cats.

King C, Masserano JM, Codd E, Byrne WL.

Sleep. 1981 Sep;4(3):259-62.

PMID:
6272385
12.

Seasonal variation in the apparent number of binding sites for 3H-opioid agonists and antagonists.

Codd EE, Byrne WL.

Life Sci. 1981 Jun 8;28(23):2577-83. No abstract available.

PMID:
6267391
13.

Solubilization of opiate receptors from human placenta.

Ahmed MS, Byrne WL, Klee WA.

Placenta Suppl. 1981;3:115-21. No abstract available.

PMID:
6306641
14.

Binding of adenosine 5'-monophosphate to bovine liver fructose 1,6-bisphosphatase.

Arneson RM, Geller AM, Byrne WL.

Enzyme. 1979;24(2):132-6.

PMID:
222577
15.

Fructose-1, 6-diphosphatase from bovine liver.

Geller AM, Byrne WL.

Methods Enzymol. 1975;42:363-8. No abstract available.

PMID:
237195
16.

Modification of the kinetics and regulatory properties of bovine hepatic fructose 1,6-diphosphatase with pyridoxal 5'-phosphate.

Marcus CJ, Byrne WL, Geller AM.

Life Sci. 1974 Nov 15;15(10):1765-80. No abstract available.

PMID:
4378098
17.

Studies on bovine hepatic fructose 1,6-diphosphatase. Substrate inhibition and the kinetic mechanism.

Marcus CJ, Geller AM, Byrne WL.

J Biol Chem. 1973 Dec 25;248(24):8567-73. No abstract available.

18.

Facilitation by alcohol of active avoidance acquisition performance in the goldfish.

Bryant RC, Petty F, Warren JL, Byrne WL.

Pharmacol Biochem Behav. 1973 Sep-Oct;1(5):523-9. No abstract available.

PMID:
4790734
19.

Effects of piracetam (SKF 38462) on acquisition, retention, and activity in the goldfish.

Bryant RC, Petty F, Byrne WL.

Psychopharmacologia. 1973 Mar 16;29(2):121-30. No abstract available.

PMID:
4709836
20.

Bovine hepatic fructose 1,6-diphosphatase: modification of the catalytic and allosteric properties by sulfhydryl reagents.

Geller AM, Byrne WL.

Arch Biochem Biophys. 1972 Dec;153(2):526-36. No abstract available.

PMID:
4350806
21.

Properties of glutaraldehyde-modified bovine hepatic fructose-1,6-diphosphatase.

Aloyo VJ, Geller AM, Marcus CJ, Byrne WL.

Biochim Biophys Acta. 1972 Nov 10;289(1):242-6. No abstract available.

PMID:
4343871
22.

Synthetic scotophobin in goldfish: specificity and effect on learning.

Bryant RC, Santos NN, Byrne WL.

Science. 1972 Aug 18;177(4049):635-6.

PMID:
5049310
23.

Bovine hepatic fructose 1,6-diphosphatase: -glycerophosphate hydrolysis-evidence for a shared active site.

Cohen HJ, Harris TM, Geller AM, Byrne WL.

Arch Biochem Biophys. 1971 Sep;146(1):144-52. No abstract available.

PMID:
4335480
24.

Modification of hepatic fructose 1,6-diphosphatase activity by proteolytic enzymes and sulfhydryl reagents.

Geller AM, Rajagopolan GT, Ellis EH, Byrne WL.

Arch Biochem Biophys. 1971 Sep;146(1):134-43. No abstract available.

PMID:
4335479
25.

Bovine hepatic fructose 1,6-diphosphatase: purification and properties.

Byrne WL, Rajagopalan GT, Griffn LD, Ellis EH, Harris TM, Hochachka P, Reid L, Geller AM.

Arch Biochem Biophys. 1971 Sep;146(1):118-33. No abstract available.

PMID:
4335478
26.

Gamma-L-glutaminyl-3,4-benzoquinone. Structural studies and enzymatic synthesis.

Weaver RF, Rajagopalan KV, Handler P, Byrne WL.

J Biol Chem. 1971 Apr 10;246(7):2015-20. No abstract available.

27.
28.

Membrane structure: lipid-protein interactions in microsomal membranes.

Trump BF, Duttera SM, Byrne WL, Arstila AU.

Proc Natl Acad Sci U S A. 1970 Jun;66(2):433-40.

29.

Molecular approaches to the central nervous system: AAAS Symposium 29-31 December 1968. Dallas, Texas.

Byrne WL.

Science. 1968 Dec 20;162(3860):1416-7. No abstract available.

PMID:
5699658
30.

Studies on the phospholipid requirement of glucose 6-phosphatase.

Duttera SM, Byrne WL, Ganoza MC.

J Biol Chem. 1968 May 10;243(9):2216-28. No abstract available.

31.

Symposium, 29-30 December 1967, AAAS Annual Meeting, New York City.

Byrne WL.

Science. 1967 Nov 24;158(3804):1081-2. No abstract available.

PMID:
17811621
32.

Depression of enzyme activity by cortisone: an effect on serine metabolism.

Fallon HJ, Byrne WL.

Endocrinology. 1967 May;80(5):847-50. No abstract available.

PMID:
6023556
33.

Alterations in serine metabolism in rats fed liquid synthetic diets.

Fallon HJ, Byrne WL.

Proc Soc Exp Biol Med. 1966 Nov;123(2):378-80. No abstract available.

PMID:
5924474
34.

Serine biosynthesis in rat liver. Regulation of enzyme concentration by dietary factors.

Fallon HJ, Hackney EJ, Byrne WL.

J Biol Chem. 1966 Sep 25;241(18):4157-67. No abstract available.

35.

Memory transfer.

Byrne WL, Samuel D, Bennett EL, Rosenzweig MR, Wasserman E.

Science. 1966 Aug 5;153(3736):658-9. No abstract available.

PMID:
5939939
36.

2-phosphoglyceric acid phosphatase: identification and properties of the beef-liver enzyme.

Fallon HJ, Byrne WL.

Biochim Biophys Acta. 1965 Jul 29;105(1):43-53. No abstract available.

PMID:
4284998
37.

Metabolism of phosphoserine. III. Mechanism of O-phosphoserine phosphatase.

NEUHAUS FC, BYRNE WL.

J Biol Chem. 1960 Jul;235:2019-24. No abstract available.

38.

Glucose-6-phosphatase and the exchange of glucose with glucose-6-phosphate.

HASS LF, BYRNE WL.

Science. 1960 Apr 1;131(3405):991-2.

PMID:
13851973
39.

Metabolism of phosphoserine. II. Purification and properties of O-phosphoserine phosphatase.

NEUHAUS FC, BYRNE WL.

J Biol Chem. 1959 Jan;234(1):113-21. No abstract available.

40.

Metabolism of phosphoserine. I. Exchange of L-serine with phosphoserine.

NEUHAUS FC, BYRNE WL.

J Biol Chem. 1959 Jan;234(1):109-12. No abstract available.

41.

O-Phosphoserine phosphatase.

NEUHAUS FC, BYRNE WL.

Biochim Biophys Acta. 1958 Apr;28(1):223-4. No abstract available.

PMID:
13535714
42.

Pentose phosphates formed by muscle aldolase.

BYRNE WL, LARDY HA.

Biochim Biophys Acta. 1954 Aug;14(4):495-501. No abstract available.

PMID:
13198907
43.

Substrate specificity of muscle aldolase.

TUNG TC, LING KH, BYRNE WL, LARDY HA.

Biochim Biophys Acta. 1954 Aug;14(4):488-94. No abstract available.

PMID:
13198906

Supplemental Content

Loading ...
Support Center